1. Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells
   Surya Kant Tripathi et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
2. The promising potential of piperlongumine as an emerging therapeutics for cancer
   Dey Parama et al, 2021, Exploration of Targeted Anti-tumor Therapy CrossRef
3. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells
   Valdenizia R. Silva et al, 2021, Cancer Communications CrossRef